患有心力衰竭的患者中低血的患病率:系统审查和元分析
Xiaoxiao Chen1,2, Rulan Yin1,3, Minxia Lu4
1Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
Nursing open
|March 6, 2025
概括
低血清化物水平的疾病 - - 低化症 - - 影响全球14%的心力衰竭患者. 本系统性审查和元分析提供了对这种日益关注的流行率的全面估计.
科学领域:
- 心脏病学 心脏病学
- 电解质不平衡导致的电解质不平衡
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题.
- 血清化物水平越来越被认为在高温管理中具有重要意义.
- 之前对HF患者中低血症患病率的估计缺乏一致性.
研究的目的:
- 为了确定被诊断为心力衰竭的患者中低血的全球患病率.
- 通过系统审查和元分析来综合现有数据.
主要方法:
- 在主要的生物医学数据库 (PubMed,Cochrane,Embase,Web of Science,CINAHL) 进行了系统的搜索,截至2022年5月24日.
- 包括观察性研究来定义低血症,并报告其在HF患者中的患病率.
- 用随机效应模型分析数据,通过Cochran的Q和I2统计评估异质性.
主要成果:
- 分析包括16篇论文,代表18项研究,涉及29,807名HF患者.
- 心力衰竭中低血的综合患病率为14.0% (95% CI:11.9%-16.2%).
- 研究国家和研究质量被确定为异质性来源;检测到出版偏差.
结论:
- 低血症在全球14%的心力衰竭患者中普遍存在.
- 需要进一步的研究,以了解高频低血的临床影响和管理.
- 解决异质性和出版偏见对于准确的流行率估计至关重要.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.7K
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
5.7K
相关概念视频
01:22Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:26Heart Failure Drugs: Inotropic Agents
488
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
488